Skip to main content

Maurizio Vecchione

Executive Vice President, Global Good & Research, United States

Maurizio Vecchione


Maurizio Vecchione is the executive vice president of the Global Good & Research group at Intellectual Ventures, where he oversees the integrated efforts of the Global Good Fund, the Intellectual Ventures Laboratory and the Institute for Disease Modeling.

With more than 30 years of industry experience in technology and life sciences, Vecchione has helped build nine startups and launch more than 50 commercial products spanning health technologies and therapeutics as well as telecommunications, information systems and material sciences. He most recently served as CEO of Arrogene, commercializing a nanotechnology platform for cancer therapeutics and diagnostics, and was CEO of telemedicine pioneer CompuMed.

Vecchione is an editorial advisory board member for IEEE Spectrum magazine. He’s also a member of the Board of Advisors for the Ronald Reagan UCLA Medical Center, the Leadership Council for UW Medicine/UW School of Public Health Department of Global Health and the Board of Trustees of the Italian Scientists and Scholars of North America Foundation.

As an inventor, Vecchione is named on multiple U.S. patents and patent applications related to imaging, image processing, nano-bio-polymers and telecommunications. He is a member of the American Physical Society, the American Chemical Society, the American Association for the Advancement of Science, the American Computing Machinery Society and the Institute of Electrical and Electronics Engineers.